ACRO BIOMEDICAL CO., LTD. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acro Biomedical Co., Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2025.
  • Acro Biomedical Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $13.7K, a 65.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $13.7K -$26.1K -65.7% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $20.3K -$25.7K -55.9% Mar 31, 2025 10-Q 2025-07-24
Q4 2024 $26.9K -$25.3K -48.5% Dec 31, 2024 10-Q 2025-08-05
Q3 2024 $33.4K +$26.8K +411% Sep 30, 2024 10-Q 2025-07-23
Q2 2024 $39.8K +$26.8K +206% Jun 30, 2024 10-Q 2025-07-23
Q1 2024 $46K +$26.7K +138% Mar 31, 2024 10-Q 2025-07-22
Q4 2023 $52.2K +$26.5K +103% Dec 31, 2023 10-K 2025-07-24
Q3 2023 $6.53K -$25.5K -79.6% Sep 30, 2023 10-Q 2025-07-11
Q2 2023 $13K -$25.2K -66% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $19.4K -$25K -56.3% Mar 31, 2023 10-Q 2023-08-02
Q4 2022 $25.7K -$24.7K -49% Dec 31, 2022 10-K 2025-07-18
Q3 2022 $32K +$25.7K +410% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $38.2K +$25.7K +206% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $44.3K +$25.7K +138% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $50.4K +$25.7K +104% Dec 31, 2021 10-K 2023-07-21
Q3 2021 $6.27K -$24.5K -79.6% Sep 30, 2021 10-Q 2021-11-22
Q2 2021 $12.5K -$24.2K -66% Jun 30, 2021 10-Q 2021-08-23
Q1 2021 $18.6K -$24K -56.3% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 $24.7K -$23.7K -49% Dec 31, 2020 10-K 2022-04-15
Q3 2020 $30.7K Sep 30, 2020 10-Q 2020-11-17
Q2 2020 $36.7K Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $42.6K Mar 31, 2020 10-Q 2020-05-19
Q4 2019 $48.4K Dec 31, 2019 10-K 2021-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.